Insufficient scRNA-seq data for expression of ELOVL3 at single-cell level.
Insufficient scRNA-seq data for expression of ELOVL3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 97% | 68.95 | 561 / 578 | 48% | 2.39 | 549 / 1155 |
breast | 89% | 111.00 | 407 / 459 | 49% | 1.96 | 552 / 1118 |
skin | 97% | 824.11 | 1760 / 1809 | 31% | 3.06 | 145 / 472 |
adrenal gland | 90% | 42.66 | 231 / 258 | 30% | 5.81 | 69 / 230 |
ovary | 17% | 4.01 | 30 / 180 | 81% | 5.15 | 349 / 430 |
adipose | 95% | 130.64 | 1147 / 1204 | 0% | 0 | 0 / 0 |
spleen | 94% | 51.63 | 226 / 241 | 0% | 0 | 0 / 0 |
uterus | 15% | 2.71 | 25 / 170 | 75% | 7.01 | 346 / 459 |
tonsil | 0% | 0 | 0 / 0 | 84% | 5.69 | 38 / 45 |
bladder | 48% | 12.57 | 10 / 21 | 36% | 1.46 | 183 / 504 |
kidney | 56% | 20.48 | 50 / 89 | 9% | 0.21 | 79 / 901 |
peripheral blood | 63% | 36.21 | 587 / 929 | 0% | 0 | 0 / 0 |
brain | 55% | 19.70 | 1445 / 2642 | 6% | 0.11 | 39 / 705 |
esophagus | 28% | 7.53 | 410 / 1445 | 30% | 1.07 | 55 / 183 |
prostate | 45% | 14.33 | 111 / 245 | 2% | 0.04 | 8 / 502 |
intestine | 27% | 7.55 | 264 / 966 | 18% | 0.55 | 93 / 527 |
stomach | 15% | 4.99 | 53 / 359 | 19% | 0.56 | 54 / 286 |
lymph node | 0% | 0 | 0 / 0 | 24% | 1.03 | 7 / 29 |
muscle | 23% | 5.43 | 187 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 19% | 10.03 | 260 / 1335 | 0% | 0 | 0 / 0 |
heart | 18% | 4.15 | 152 / 861 | 0% | 0 | 0 / 0 |
liver | 3% | 0.52 | 6 / 226 | 14% | 0.53 | 58 / 406 |
pancreas | 2% | 0.38 | 5 / 328 | 12% | 0.34 | 22 / 178 |
thymus | 11% | 2.54 | 72 / 653 | 2% | 0.03 | 14 / 605 |
eye | 0% | 0 | 0 / 0 | 3% | 0.10 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0042761 | Biological process | very long-chain fatty acid biosynthetic process |
GO_0034626 | Biological process | fatty acid elongation, polyunsaturated fatty acid |
GO_0036109 | Biological process | alpha-linolenic acid metabolic process |
GO_0019367 | Biological process | fatty acid elongation, saturated fatty acid |
GO_0043651 | Biological process | linoleic acid metabolic process |
GO_0034625 | Biological process | fatty acid elongation, monounsaturated fatty acid |
GO_0035338 | Biological process | long-chain fatty-acyl-CoA biosynthetic process |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0006636 | Biological process | unsaturated fatty acid biosynthetic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005515 | Molecular function | protein binding |
GO_0009922 | Molecular function | fatty acid elongase activity |
Gene name | ELOVL3 |
Protein name | Very long chain fatty acid elongase 3 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL3) (Cold-inducible glycoprotein of 30 kDa) (ELOVL fatty acid elongase 3) (ELOVL FA elongase 3) (Elongation of very long chain fatty acids protein 3) (Very long chain 3-ketoacyl-CoA synthase 3) (Very long chain 3-oxoacyl-CoA synthase 3) |
Synonyms | CIG30 |
Description | FUNCTION: Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that exhibits activity toward saturated and unsaturated acyl-CoA substrates with higher activity toward C18 acyl-CoAs, especially C18:0 acyl-CoAs. May participate in the production of saturated and monounsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. . |
Accessions | ENST00000370005.4 Q9HB03 |